ZFIN ID: ZDB-FISH-150901-21109
Fish name: s356tTg
Genotype: s356tTg
Targeting Reagent: none
HUMAN DISEASE MODELED by s356tTg
Human Disease Conditions Citations
drug-induced hearing loss chemical treatment by environment: cisplatin Hu et al., 2020
GENE EXPRESSION
Gene expression in s356tTg
PHENOTYPE
Phenotype in s356tTg
Phenotype Conditions Figures
anterior lateral line neuromast has extra parts of type neuromast hair cell, abnormal chemical treatment: pharmaceutical Fig. 6 from Jacques et al., 2014
hair cell regeneration process quality, normal chemical treatment by environment: neomycin Fig. 6 with image from Kim et al., 2018
hair cell anterior macula disorganized, abnormal standard conditions Fig. 1 with image from Millimaki et al., 2010
hair cell anterior macula protruding out of macula utricle, abnormal standard conditions Fig. 1 with image from Millimaki et al., 2010
inner ear receptor cell development increased duration, abnormal standard conditions Fig. 1 with image from Millimaki et al., 2010
macula has extra parts of type hair cell, abnormal chemical treatment: all-trans-retinoic acid Fig. 8 with image from Maier et al., 2014
macula has fewer parts of type hair cell, abnormal chemical treatment: 4-(diethylamino)benzaldehyde Fig. 8 with image from Maier et al., 2014
macula utricle has fewer parts of type hair cell, abnormal standard conditions Fig. 1 with image from Millimaki et al., 2010
neuromast lacks parts or has fewer parts of type neuromast hair cell, abnormal chemical treatment: ethanol Fig. 2 with image from Uribe et al., 2013
neuromast apoptotic process increased occurrence, abnormal chemical treatment: neomycin Fig. 3 from Rah et al., 2015
neuromast apoptotic process increased occurrence, ameliorated chemical treatment: drug, chemical treatment: neomycin Fig. 3 from Rah et al., 2015
neuromast cell death increased occurrence, abnormal chemical treatment: ethanol Fig. 4 with image from Uribe et al., 2013
neuromast cell population proliferation decreased occurrence, abnormal chemical treatment: ethanol Fig. 3 with image from Uribe et al., 2013
neuromast kinocilium disorganized, abnormal chemical treatment by environment: neomycin Fig. 5 with image from Chang et al., 2016
neuromast kinocilium morphology, ameliorated chemical treatment by environment: neomycin, chemical treatment by environment: sodium selenate Fig. 5 with image from Chang et al., 2016
neuromast stereocilium disorganized, abnormal chemical treatment by environment: neomycin Fig. 5 with image from Chang et al., 2016
neuromast stereocilium morphology, ameliorated chemical treatment by environment: neomycin, chemical treatment by environment: sodium selenate Fig. 5 with image from Chang et al., 2016
neuromast hair cell amount, ameliorated chemical treatment by environment: neomycin, chemical treatment by environment: sodium selenate Fig. 2 with imageFig. 4 with image from Chang et al., 2016
neuromast hair cell apoptotic, abnormal chemical treatment by environment: neomycin Fig. 3 with image from Chang et al., 2016
neuromast hair cell damaged, abnormal chemical treatment by environment: neomycin Fig. 4 with imageFig. 6 with image from Chang et al., 2016
neuromast hair cell decreased amount, abnormal chemical treatment by environment: neomycin Fig. 2 with imageFig. 4 with image from Chang et al., 2016
neuromast hair cell decreased amount, abnormal chemical treatment: neomycin Fig. 1Fig. 2 from Rah et al., 2015
neuromast hair cell decreased amount, abnormal chemical treatment by environment: cisplatin Fig. 1 from Hu et al., 2020
neuromast hair cell GFP expression decreased amount, abnormal chemical treatment by environment: cisplatin Fig. 1 from Hu et al., 2020
neuromast hair cell decreased amount, abnormal chemical treatment: tranylcypromine hydrochloride Fig. 1 with image from He et al., 2013
neuromast hair cell decreased amount, ameliorated chemical treatment: drug, chemical treatment: neomycin Fig. 1Fig. 2 from Rah et al., 2015
neuromast hair cell decreased functionality, abnormal chemical treatment: ethanol Fig. 2 with image from Uribe et al., 2013
neuromast hair cell morphology, ameliorated chemical treatment by environment: neomycin, chemical treatment by environment: sodium selenate Fig. 4 with imageFig. 6 with image from Chang et al., 2016
neuromast hair cell apoptotic process increased occurrence, abnormal chemical treatment by environment: neomycin Fig. 3 with image from Chang et al., 2016
neuromast hair cell apoptotic process process quality, ameliorated chemical treatment by environment: neomycin, chemical treatment by environment: sodium selenate Fig. 3 with image from Chang et al., 2016
neuromast hair cell cytoplasm degenerate, abnormal chemical treatment by environment: neomycin Fig. 6 with image from Chang et al., 2016
neuromast hair cell mitochondrion swollen, abnormal chemical treatment by environment: neomycin Fig. 6 with image from Chang et al., 2016
neuromast hair cell nucleus condensed, abnormal chemical treatment by environment: neomycin Fig. 6 with image from Chang et al., 2016
neuromast hair cell regeneration decreased occurrence, abnormal physical alteration: anatomical structure, chemical treatment: valproic acid, chemical treatment: neomycin sulfate Fig. 1 from He et al., 2014
neuromast hair cell regeneration decreased occurrence, abnormal physical alteration: anatomical structure, chemical treatment: trichostatin A, chemical treatment: neomycin sulfate Fig. 1 from He et al., 2014
otic vesicle hair cell amount, abnormal chemical treatment: SU5402 Fig. 2 with image from Maier et al., 2014
otic vesicle hair cell amount, ameliorated chemical treatment by environment: alpha-cyano-4-hydroxycinnamic acid, chemical treatment by environment: lactate Figure 5 from Kantarci et al., 2020
otic vesicle hair cell amount, ameliorated chemical treatment by environment: 2-deoxy-D-glucose, chemical treatment by environment: lactate Figure 5 from Kantarci et al., 2020
otic vesicle hair cell amount, ameliorated chemical treatment by environment: enzyme inhibitor, chemical treatment by environment: lactate Figure 5 from Kantarci et al., 2020
otic vesicle hair cell decreased amount, abnormal chemical treatment by environment: alpha-cyano-4-hydroxycinnamic acid Figure 5 from Kantarci et al., 2020
otic vesicle hair cell decreased amount, abnormal chemical treatment by environment: enzyme inhibitor Figure 5 from Kantarci et al., 2020
otic vesicle hair cell decreased amount, abnormal chemical treatment by environment: 2-deoxy-D-glucose Figure 5 from Kantarci et al., 2020
otic vesicle hair cell disorganized, abnormal chemical treatment: SU5402 Fig. 2 with image from Maier et al., 2014
otolith position, abnormal chemical treatment: SU5402 Fig. 2 with image from Maier et al., 2014
otolith regeneration process quality, normal chemical treatment by environment: neomycin Fig. 6 with image from Kim et al., 2018

CITATIONS  (90)